On one hand, inflammasomes such as NLRP3 and AIM2 can suppress tumorigenesis by enhancing anti-tumor immunity through the activation of caspase-1 and subsequent maturation and release of pro-inflammatory cytokines like IL-1β and IL-18, which recruit and activate immune cells (20). The gene discussed is AIM2; the disease is neoplasm.